Interim analysis from TRIC-1 a study of metformin with peginterferon alfa-2a and ribavirin in treatment naive genotype 1 chronic hepatitis C with insulin resistance

被引：2
|
作者：
Romero-Gomez, M. [1 ]
Diago, M. [2 ]
Andrade, R. J. [3 ]
Calleja, J. L. [4 ]
Salmeron, J. [5 ]
Fernandez-Rodriguez, C. M. [6 ]
Sola, R. [7 ]
Herrerias, J. M. [8 ]
Garcia-Samaniego, J. [9 ]
Moreno-Otero, R.
Olveira, A.
Nunez, O.
De la Mata, M.
Jorquera, E.
Morillas, R. M.
Dalmau, B.
Martin-Vivaldi, R.
Arenas-Ruiz, J. I.
机构：
[1] Hosp Univ Valme, UCM Digest Dis & Ciberehd, Seville, Spain
[2] Hosp Gen Valencia, Hepatol Sect, Valencia, Spain
[3] Hosp Virgen Victoria, Hepatol Sect, Malaga, Spain
[4] Hosp Puerta Hierro, Dept Gastroenterol, Madrid, Spain
[5] Hosp San Cecilio, Digest Dis Unit, Granada, Spain
[6] Fdn Hosp Alcorcon, Gastroenterol Unit, Madrid, Spain
[7] Hosp Mar, Hepatol Sect, Barcelona, Spain
[8] Hosp Virgen Macarena, Gastroenterol Unit, Seville, Spain
[9] Hosp Carlos III, Hepatol Unit, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)61003-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1001
引用
收藏
页码：S375 / S375
页数：1
相关论文
共 50 条
  • [1] METFORMIN WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN THE TREATMENT OF NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS WITH INSULIN RESISTANCE (TRIC-1): FINAL RESULTS OF A RANDOMIZED AND DOUBLE-BLINDED TRIAL
    Romero-Gomez, Manuel
    Diago, Moises
    Andrade, Raul J.
    Calleja, Jose Luis
    Salmeron, Javier
    Fernandez-Rodriguez, Conrado M.
    Sola, Ricard
    Herrerias, Juan M.
    Carmona, Isabel
    Garcia-Samaniego, Javier
    Moreno-Otero, Ricardo
    Morillas, Rosa
    Ramirez, Carmen
    De la Mata, Manuel
    Giner, Pilar
    Olveira, Antonio
    Nunez, Oscar
    Jorquera, Francisco
    Duran, Santiago
    Martin-Vivaldi, Rafael
    [J]. HEPATOLOGY, 2008, 48 (04) : 380A - 380A
  • [2] Treatment of Insulin Resistance with Metformin in Naive Genotype 1 Chronic Hepatitis C Patients Receiving Peginterferon Alfa-2a Plus Ribavirin
    Romero-Gomez, Manuel
    Diago, Moises
    Andrade, Raul J.
    Calleja, Jose L.
    Salmeron, Javier
    Fernandez-Rodriguez, Conrado M.
    Sola, Ricard
    Garcia-Samaniego, Javier
    Herrerias, Juan M.
    De la Mata, Manuel
    Moreno-Otero, Ricardo
    Nunez, Oscar
    Olveira, Antonio
    Duran, Santiago
    Planas, Ramon
    [J]. HEPATOLOGY, 2009, 50 (06) : 1702 - 1708
  • [3] Interim analysis results from a phase 2 study of telaprevir with peginterferon alfa-2a and ribavirin in treatment-naive subjects with hepatitis C
    Jacobson, Ira M.
    Everson, Gregory T.
    Gordon, Stuart C.
    Kauffman, Robert
    McNair, Lindsay
    Muir, Andrew
    McHutchison, John G.
    [J]. HEPATOLOGY, 2007, 46 (04) : 315A - 316A
  • [4] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b
    Flisiak, Robert
    Kawazoe, Seiji
    Znoyko, Olga
    Assy, Nimer
    Gadano, Adrian
    Kao, Jia-Horng
    Lee, Kwan-Sik
    Zwirtes, Ricardo
    Portsmouth, Simon
    Dong, Yuping
    Xu, Dong
    Kumada, Hiromitsu
    Srinivasan, Subasree
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643
  • [5] Peginterferon alfa-2a and ribavirin in African American and Caucasian patients with chronic hepatitis C, genotype 1
    Conjeevaram, HS
    Fried, MW
    Jeffers, LJ
    Terrault, N
    Wiley-Lucas, TE
    Afdhal, N
    Brown, RS
    Belle, SH
    Robuck, PR
    Howell, CD
    [J]. HEPATOLOGY, 2005, 42 (04) : 275A - 276A
  • [6] PEGINTERFERON ALFA-2A PLUS RIBAVIRIN COMBINATION TREATMENT IN CHRONIC HEPATITIS C POSTRENAL TRANSPLANT PATIENTS: AN INTERIM ANALYSIS
    Sanai, Faisal M.
    Mousa, Dujanah H.
    Aleid, Hassan
    AlShoail, Ghada
    AlMdani, Abdullah S.
    Al-Ashgar, Hamad I.
    Almeshari, Khalid A.
    Bzeizi, Khalid I.
    [J]. HEPATOLOGY, 2010, 52 (04) : 789A - 789A
  • [7] Chronic hepatitis C genotype 4:: Efficacy and safety of the treatment with peginterferon alfa-2a plus ribavirin
    Diago, M.
    Boadas, J.
    Planas, R.
    Sola, R.
    del Olmo, J. A.
    Crespo, J.
    Erdozain, J. C.
    Anton, M. D.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S292 - S292
  • [8] Impact of gender on virologic responses rates in genotype 1 chronic hepatitis C patients with peginterferon alfa-2a and ribavirin treatment
    Yu, J. -W.
    Sun, L. -J.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S86 - S86
  • [9] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [10] Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment
    Reddy, K. Rajender
    Shiffman, Mitchell L.
    Morgan, Timothy R.
    Zeuzem, Stefan
    Hadziyannis, Stephanos
    Hamzeh, Fayez M.
    Wright, Teresa L.
    Fried, Michael
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (01) : 124 - 129
12345